what is known already: A growing number of studies have identified a range of phenotypic differences between IVF and naturally conceived pre-pubertal children; for example, birthweights are lower following a fresh compared with a thawed embryo transfer. study design, size, duration: This retrospective cohort study included IVF children (n ¼ 96) born at term (.37 weeks) after a singleton pregnancy from the transfer of either fresh or thawed embryos in New Zealand. Between March 2004 and November 2008, these children were subjected to clinical assessment before puberty.
Introduction
For people experiencing infertility, the potential impact of fertility treatment on a child's health is likely to be a secondary consideration compared with the desire to conceive. There is, however, growing evidence that fertility treatment may have subtle effects on offspring phenotype. For example, decreased birthweights are reported after the transfer of a fresh embryo (Belva et al., 2008; Shih et al., 2008; McDonald et al., 2009; Pelkonen et al., 2010; Pinborg et al., 2010) and recent data suggests an increased risk of being born large for gestational age after the transfer of a thawed embryo (Pinborg et al., 2014) . Despite over 5 million IVF children being born, relatively few studies have investigated phenotypic characteristics of IVF children beyond birth (see reviews: Middelburg et al., 2008; Savage et al., 2011; Hart and Norman, 2013a,b) . An increasing number of these studies have identified distinct phenotypic differences in growth rate, weight gain, height and blood pressure in later (pre-pubertal) assessments of IVF children when compared with naturally conceived children (Miles et al., 2007; Ceelen et al., 2009; Seggers et al., 2014) . This is coupled with the ongoing controversy as to whether an increased risk of imprinting related disorders (Maher, 2005; Ceelen et al., 2008; Wilkins-Haug, 2009) or birth defects occur in IVF offspring (Hansen et al., 2005; Davies et al., 2012) .
Instead of studying possible effects on offspring phenotype, research has primarily focused on improving pregnancy rates by determining factors that are associated with or can predict a successful live birth outcome. Factors linked to outcomes include a mother's age and her hormone and metabolite concentrations (Srouji et al., 2005; Carrera-Rotllan et al., 2007; Anifandis et al., 2010) , as well as embryo developmental speed and quality (Volpes et al., 2004; Terriou et al., 2007; van Loendersloot et al., 2010) . Prediction models that aim to ascertain the likelihood of an IVF pregnancy and live birth have consequently arisen (Leushuis et al., 2009; Banerjee et al., 2010; Dessolle et al., 2011; Nelson and Lawlor, 2011) .
The relatively recent undertaking of IVF technology, combined with the low but rapidly increasing number of IVF offspring in late childhood or adulthood, means no study has attempted to determine whether variables around the time of conception, specifically in relation to the IVF process, can predict the phenotype of the subsequent offspring. The aim of the current study was therefore to investigate whether the phenotype of IVF children can be associated with peri-conception variables before Day 18 of pregnancy. Data were utilized from a previously wellcharacterized cohort (Miles et al., 2007; Green et al., 2013) of singleton pre-pubertal children in which phenotype differences have been evident compared with naturally conceived children. Retrospective investigation of a large number of parental, laboratory and embryonic variables provided 36 derived factors. These factors were analysed by multiple stepwise linear regression, using similar criteria to Banerjee et al. (2010) and data analyses as Andersen et al. (2011) , with respect to three easily obtained childhood measures, i.e. birthweight and childhood BMI and height standard deviation scores (SDSs) that importantly factor in genetic (parental) influences. Thus, the ultimate aim of this proof-of-principle study was to potentially identify peri-conception variables that could provide additional information to aid the decisions of clinical practitioners.
Materials and Methods

Study population
The study recruited healthy pre-pubertal IVF children between the ages of 3.5 and 11 years of age, born at term (.37 weeks gestation) after a singleton pregnancy. The children were born following treatment at Fertility Associates clinics in Auckland and Hamilton, New Zealand (Miles et al., 2007; Green et al., 2013) . IVF children were conceived via the transfer of either a fresh (IVF F ) or thawed (IVF T ) embryo. Exclusion criteria were the use of donor gametes (sperm or oocyte), more than one fetal sac identified at 7 -8 weeks gestation, and women having a known medical syndrome, chronic illness, or receiving regular medications prior to or during treatment and pregnancy (e.g. gestational diabetes).
Ethical approval
Ethics approval (MEC/06/11/148) was provided by the Auckland Ethics Committee. Written and verbal informed consent was obtained for all participants.
Ovarian stimulation protocol, in vitro fertilization and embryo culture Ultrasonography was used in ovarian stimulation protocols to measure the diameter of growing follicles .15 mm. When at least two of the lead follicles were 18 mm in diameter, hCG (10 000 IU Profasi; Serono Laboratories, Aubonne, Switzerland) was administered to trigger ovulation. Oocyte retrieval was performed 34-36 h after the hCG trigger and fertilization was performed by IVF or intracytoplasmic sperm injection (ICSI). Embryos were grown in commercial human serum albumin supplemented embryo culture media from either Medicult (now Origio; Måløv, Denmark) or, after January 1999, Scandinavian IVF Science (now Vitrolife; Göteborg, Sweden).
Embryo development, quality and transfer procedure Embryo development was recorded as cell number and quality graded on a 1 -5 scoring system (1 ¼ fragmentation .50%, very uneven blastomeres; 5 ¼ no fragmentation, evenly sized blastomeres). Embryos graded 3 -5 were considered suitable for transfer or freezing. During this period, embryos were transferred on Day 2 after oocyte collection. Alternatively, on Day 2 embryos were frozen using a standard propanediol method (Cohen et al., 1988) , before being thawed and assessed prior to transfer on Day 2 of a subsequent cycle. Thawed embryos were transferred in either a natural menstrual cycle tracked by daily measurement of blood LH or in a manufactured cycles using estradiol valerate (4 mg/day Progynova; Bayer Schering Pharma, Auckland, New Zealand) and micronized progesterone [600 mg/day Utrogestan; Pharmaco (NZ) Ltd., Auckland, New Zealand] . To compare thawed with fresh embryos, development and quality data of an embryo at transfer were used in the analysis. In mothers who received more than one embryo, the mean cell number and embryo quality score was used in the analyses. (Niklasson et al., 1991) , as well as child's age at assessment were recorded. Maternal age, height and weight were retrieved from IVF patient records, while paternal height and weight were obtained during the study. Body mass index (BMI) was calculated, and mid-parental height and mid-parental BMI were corrected to a SDS (Tanner and Whitehouse, 1976) . Each child's weight, standing height (measured using a Harpenden stadiometer), and BMI were calculated as an SDS, and corrected for mid-parental height and mid-parental BMI that factor in the child's sex (Tanner and Whitehouse, 1976; Cole et al., 1995) .
Descriptive and anthropometric measurements
Parental and IVF treatment variables
Data were retrieved on parental characteristics, clinical diagnoses, IVF treatment protocol and response, embryology data, culture conditions and treatment outcomes from the retrospective mining of the clinics' database and patient files for 69 variables for each of the IVF pregnancies in the study cohort (Supplementary data, Table SI) . High-quality data with .90% completeness was set as the minimum requirement for the variables. Of the 69 variables, 20 were factors known to physicians prior to starting an IVF cycle (pre-IVF variables) and 31 variables became available during or at the conclusion of an IVF treatment (protocol and treatment variables). A further 18 variables were collected or determined at the pre-pubertal assessment of the children (offspring phenotypic variables). From these 69 variables, 36 derived factors were calculated, classified as continuous or categorical. A description for each variable and factor, as to how it was derived and what it refers, is outlined (Supplementary data, Table SI ). To standardize between any differences in the timing of patient procedures, follicular and oocyte characteristics were adjusted relative to the time of the hCG trigger and oocyte retrieval, respectively.
Statistical analysis
The study cohort included eight sibling pairs, with all but one pair consisting of one IVF F followed by one IVF T child. This was taken into account in the linear mixed model by specifying the oocyte collection cycle as a random effect. Differences in anthropometric measurements (birthweight SDS, mid-parental corrected BMI SDS and mid-parental corrected height SDS) between children were investigated using a generalized linear mixed model, following similar criteria to Banerjee et al. (2010) and similar data analyses to Andersen et al. (2011) . Analyses were run using the Proc Mixed procedure of SAS software version 9.1 (SAS Institute). Linear regression analysis was used to investigate relationships between embryo characteristics (development and quality) at transfer, as well as between these characteristics and 12 parental and IVF treatment variables.
Data collected for the 69 variables resulted in 36 derived factors. These 36 derived factors were then analysed in an unbiased fashion without specific ranking a priori. For each of the three end-point phenotype childhood measures (birthweight SDS, mid-parental corrected BMI SDS and mid-parental corrected height SDS), the regression model contained the derived factors that accounted for the highest variation of that measure. Laboratory and phenotypic derived factors were chosen progressively and automatically, with stepwise forward selection regression, where at each step factors were tested in all possible order combinations and the factor with the largest variance ratio was added, and this was followed by an all subsets regression on the top 16 derived factors in each case. A backward elimination regression was consequently performed to confirm the influence of each factor, which identified only those derived factors that were significantly related to the end-point measure. This analysis undertaken in GenStat (VSN International, 2013) determined the contribution to the end-point phenotypic measure made by each factor independent of the other predictive factors. Separate analyses were undertaken for each of the three phenotypic end-point measures, with model derived factors excluded if these were used in the calculation of that specific end-point measure. The significance for the models and the main predictive factors was set, respectively, at P , 0.05. Reported model output include regression estimates, factor means with SEM and 95% confidence intervals (CIs). Probability values of ,0.05 were considered statistically significant.
Results
Participant characteristics and measures
A total of 137 children who met inclusion criteria were approached for potential recruitment and of these 115 (84%) were successfully recruited. Causes of infertility, the proportion of children conceived using ICSI, gestation length, birthweight SDS and maternal age were similar among the children recruited into the study and those who did not take part or met the inclusion criteria. From the 115 children recruited and characterized in previous studies (Miles et al., 2007; Green et al., 2013) , 17 children were excluded due to ,90% completeness of peri-conception data. In addition, two children were excluded as they were derived from the transfer of blastocyst stage embryo, rather than a cleavage stage embryo. Overall, data from 96 children were analysed and included in the study. These children comprised those conceived from the transfer of a fresh embryo (IVF F ; n ¼ 60; male ¼ 30, female ¼ 30) and those from a thawed embryo (IVF T ; n ¼ 36; male ¼ 17, female ¼ 19). Summary data for each of the 36 predictive factors analysed are shown in Table I .
Embryo development and quality
There was no relationship (P , 0.1) between mean cell number and mean embryo quality score. Fresh embryos (n ¼ 60) when compared with thawed embryos (n ¼ 36) had fewer cells (3.6 + 0.1 versus 4.6 + 0.3, P , 0.001) but were of better quality (3.8 + 0.1 versus 3.5 + 0.1, P , 0.05). Linear regression analysis between mean embryo characteristics (quality score and development, i.e. cell number) at transfer and 12 follicular and treatment variables, including maternal age, FSH dosage, number of days stimulated, peak estradiol concentration, number and size of follicles, as well as fertilization method and culture media identified a significant relationship with only one variable. Embryo development (P ¼ 0.04, slope 0.134 + 0.064) but not mean embryo quality score (P , 0.1) was positively associated with the mean adjusted diameter of the lead follicles at oocyte collection. The mean number of embryos transferred was 2.3 + 0.1 for fresh and 1.6 + 0.1 for thawed cycles. Mean daily maternal circulating b-hCG concentration calculated from the difference between the two concentrations corrected for the actual number of days.
Pregnancy and birth rates
Over the period in which children in the study were conceived, for women ,37 years old receiving a long GnRH agonist stimulation regimen, comparable with the majority of mothers in the study cohort, the clinical pregnancy and birth rates per fresh embryo transfer were 27 and 23%, and per thawed embryo transfer 17 and 14%, respectively, for the whole clinic.
Anthropometric measurements
The mean birthweight SDS for all children was 0.02 + 0.11 (Table I) , which equated to 3.5 kg. The mean age of children at clinical assessment was 6.2 + 0.2 years old, with no difference (P . 0.1) in mean age at assessment between genders. When data were analysed with respect to a single variable, there was a difference in birthweight SDS (P ¼ 0.02; IVF F 20.18 + 0.16 and IVF T 0.35 + 0.21) but not in midparental corrected height SDS or mid-parental corrected BMI SDS (P , 0.1) between IVF F and IVT T children.
Association between peri-conception measurements and phenotype end-points
Multiple stepwise regressions identified associations between a number of the 36 derived factors and the three selected end-point childhood measures (birthweight SDS, mid-parental corrected BMI SDS and midparental corrected height SDS). The independent contribution, positive or negative, of factors found to be significantly (P , 0.05) associated with each of the three end-point measures are summarized (Table II) . Whether the embryos were fresh or thawed at transfer was the only factor found to be associated with birthweight SDS (P ¼ 0.02, 95% CI fresh minus thawed: 21.047 to 20.006; Table I ), irrespective of child sex. Birthweight SDS itself had a strong positive association (P ¼ 0.003, slope 0.339 + 0.100; Table I ) with mid-parental corrected BMI SDS of the children. This relationship was evident for children born from both a fresh and thawed embryo. One categorical and three continuous derived factors were associated with the mid-parental corrected height SDS of children (Table II) . The log number of follicles aspirated at oocyte retrieval was positively associated with child height (P ¼ 0.05, slope 1.011 + 0.497), the diameter of the lead follicles at oocyte collection (P , 0.001, slope 20.144 + 0.040) and the mean embryo quality score (P ¼ 0.008, slope 20.425 + 0.157) were both negatively associated with child height. In addition, the transfer of a fresh embryo was positively associated with taller stature (P , 0.001, 95% CI 0.275-0.750).
Discussion
The present study identified several peri-conception factors that were related to the three IVF childhood phenotype end-point measures: birthweight and childhood BMI and height. Most notably, an increased height of IVF children was strongly related to a smaller diameter of lead follicles at oocyte retrieval and to the transfer of a poorer quality embryo.
Several studies that have related neonate and childhood characteristics with IVF methodology have focused on aspects of in vitro culture, including the impact of culture media (Eaton et al., 2011; Eskild et al., 2013) , length of embryo culture (Kallen et al., 2010; Makinen et al., 2013; Zhu et al., 2014) and the freezing of embryos (Belva et al., 2008; Shih et al., 2008) . The current study suggests that follicular characteristics at the time of the ovulation trigger and embryo quality are also important. The recruitment and recovery of increased numbers of smaller diameter, potentially less mature, follicles was associated with taller children. Equally, the transfer of both fresh and thawed poor-quality embryos was related to increased child height. It is unknown whether this increased height is a beneficial or detrimental long-term health characteristic; however, the present study is believed to be the first report associating follicle characteristics and embryo quality with a child's height.
In terms of possible mechanisms of how follicular characteristics impact height, our findings may point towards altered nuclear and cytoplasmic maturation, as well as epigenetic imprinting (Santos et al., 2010; Plourde et al., 2012; Inbar-Feigenberg et al., 2013) . For example in mice, high concentrations of FSH can accelerate oocyte nuclear maturation (Roberts et al., 2005) . Animal studies show that ovarian stimulation regimens alone perturb imprinted oocyte and embryo gene expression (Market-Velker et al., 2010; Sanchez et al., 2010; Chu et al., 2012) , and can reduce fetal growth . Notably, it is hypothesized that genes that acquire their imprints late in oocyte development are the most susceptible to perturbations (Gosden et al., 2003; Fortier et al., 2008) . Thus, in the current study, if these genes are also related to phenotypic traits, such as height, then potentially ovarian stimulation, especially in potentially immature oocytes from smaller follicles, may alter the methylation status and result in subtle changes in offspring height as evident in the present study. In humans, ovarian stimulation is known to impact child height (Savage et al., 2012) and recent data from Seggers et al. (2014) has described adverse effects of ovarian stimulation, distinct to those of IVF, on cardiometabolic outcomes of IVF children. Smaller (16 -18 mm diameter) follicles are also associated with a decrease in maturation and fertilization rates, and the production of poorer quality embryos (Rosen et al., 2008) . Thus, there is a body of evidence to suggest that follicle diameter at the ovulation trigger needs to be considered as a possible contributor to offspring phenotype and longterm health.
This study also identified that the quality of the embryo at transfer, irrespective of whether it was fresh or thawed, was negatively associated with child height. Although potential mechanisms are unclear, what is apparent is the phenotypic plasticity of the oocyte and embryo appear to be greatest when they are less mature and of poorer quality, respectively. Whether the plasticity of the cleavage stage embryo at transfer differs from that of a blastocyst stage embryo needs to be ascertained. However, the relationship between embryo quality and child height is further reinforced by embryo quality also being a predictive factor for live birth rate (Roberts et al., 2010) .
In addition to an association with child height, the transfer of an embryo back into the uterine environment during the same (fresh) compared with a subsequent (thawed) cycle was associated with a decreased birthweight, consistent with previous studies (Shih et al., 2008; Pelkonen et al., 2010) . Birthweight itself was positively related to mid-parental corrected BMI of IVF children. A positive association between birthweight and BMI is well-documented in naturally conceived children (Oken and Gillman, 2003; Eriksson et al., 2008) . It is postulated that the presence of GnRH receptors in cumulus -oocyte complexes and preimplantation embryos Raga et al., 1999) , as well as in the endometrium (Grundker et al., 2002 ) potentially provides a mechanism by which ovarian stimulation can directly impact offspring phenotype. An alternative or additional indirect mechanism is provided by the subsequent elevated estrogen concentrations that may act to advance the endometrium to impact phenotype (Savage et al., 2012) . This theory is potentially supported by the current finding that increased follicle numbers are associated with a taller phenotype as the artificially increased number of large follicles could be responsible for the production of supraphysiological estradiol concentrations. Taken together the current findings suggest that, laboratory protocols, in combination with the indirect actions of ovarian stimulation regimens on endometrial and luminal characteristics (Evans et al., 2012) , may therefore impact not only birthweight but perhaps catch-up growth ex utero (Ong et al., 2000; Koivurova et al., 2003) or the setting of a different post-natal growth trajectory (Ceelen et al., 2009) .
One of the strengths of the present study is that data were analysed a priori with no assumptions about relationships or the relative influence of variables to one another. The use of SDS, strict inclusion criteria, limiting many potential confounders and the large number of 69 variables (spanning pre-IVF, IVF and early pregnancy characteristics), as well as the high level of completeness of datasets (.90%), makes this a robust dataset, similar to those successfully employed in predictive models (Banerjee et al., 2010; Andersen et al., 2011) . The associations between the peri-conception factors and the childhood measures were also thoroughly tested to ensure a true relationship, rather than one generated by chance. These strengths offset the retrospective nature of the study, at a time when single embryo transfer was not routinely undertaken. The removal of twin pregnancies at the first scan, however, addressed, with some confidence, any possible effects of an additional embryo. A further strength of the current study is that the majority of mothers received the same GnRH agonist stimulation protocol and were between 30 and 36 years old. Hence data were not confounded by the use of different stimulation regimens and advanced (.40 years) maternal age. Future studies investigating these variables would be of interest, as it is proposed that both would impact offspring phenotype. In the present study, there was no association of maternal age with any of the three end-point phenotype measures, however, increased maternal age is known to decrease first trimester embryonic growth trajectories (van Uitert et al., 2013) and increase child height (Savage et al., 2013) . This study has identified several key associations between periconception factors and three end-point phenotypic measures in a well--efined cohort of pre-pubertal IVF children. While this study has several shortcomings, including the relatively small numbers, multiple embryo transfer for most singleton conceptions, and the study time period in which substantial changes in clinical practice occurred, including an increase in use of sequential media. The current analysis does account for a large number of these variables and still found no effect of factors commonly highlighted as potentially influencing phenotype, such as culture medium. This proof of principle study does, however, providence evidence that the diameter of the lead follicles at the ovulation trigger, and the quality of embryos at transfer are associated with growth of children pre-puberty. Large cohorts from multiple clinics are required to confirm whether these findings commonly occur and ultimately, to test these factors as possible predictors of phenotype. Cross-sectional and longitudinal follow-up studies of IVF children are logistically difficult, but are needed to ascertain which variables in IVF treatment impact the growth and health of children, and to what extent. Based on the current findings, future studies should include ovarian stimulation and embryo quality when investigating factors that influence phenotype in IVF children.
Conclusions
This analysis of 36 derived factors, including parental and IVF treatment and laboratory factors as well as embryonic characteristics, identified, through multiple stepwise regressions, individual influences of these periconception factors on the three end-point childhood measures of phenotype. Birthweight, childhood BMI and height were associated with several factors, including whether children were born following the transfer of a fresh or thawed embryo. The most notable findings were that increased child height was associated with a smaller mean diameter of lead follicles at oocyte retrieval and with the transfer of a poorer quality embryo. This is the first study associating these characteristics with a pre-pubertal child's phenotype.
Supplementary data
Supplementary data are available at http://humrep.oxfordjournals.org/.
